The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ARIAD Pharmaceuticals Inc

Nasdaq: ARIA
Last

(U.S.) $8.42

Today's change+0.16 +1.94%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

ARIAD Pharmaceuticals Inc

Nasdaq: ARIA
Last

(U.S.) $8.42

Today's change+0.16 +1.94%
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.

ARIAD Pharmaceuticals Inc Hits New 20-day High

ARIAD Pharmaceuticals Inc closed up sharply Wednesday, rallying (U.S.)$0.16 or 1.94% to (U.S.)$8.42 and setting a new 20-day high. Over the last five days, shares have gained 10.35% and 34.72% year to date. Shares have outperformed the S&P 500 by 4.99% during the last year.

Key company metrics

  • Open(U.S.) $8.30
  • Previous close(U.S.) $8.26
  • High(U.S.) $8.45
  • Low(U.S.) $8.24
  • Bid / Ask(U.S.) $8.37 / (U.S.) $8.45
  • YTD % change+34.72%
  • Volume4,321,285
  • Average volume (10-day)4,887,909
  • Average volume (1-month)4,313,457
  • Average volume (3-month)4,242,819
  • 52-week range(U.S.) $4.37 to (U.S.) $10.07
  • Beta1.92
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.23
Updated July 27 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue36372929
Total other revenue--------
Total revenue36372929
Gross profit35362929
Total cost of revenue0000
Total operating expense83898588
Selling / general / administrative36443749
Research & development44454839
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)3------
Other operating expenses, total--------
Operating income-48-53-56-59
Interest income (expense), net non-operating-5-5-5-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-54-58-61-63
Income after tax-54-60-55-63
Income tax, total02-60
Net income-54-60-55-63
Total adjustments to net income--------
Net income before extra. items-54-60-55-63
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-54-60-55-63
Inc. avail. to common incl. extra. items-54-60-55-63
Diluted net income-54-60-55-63
Dilution adjustment000--
Diluted weighted average shares190189189189
Diluted EPS excluding extraordinary itemsvalue per share-0.28-0.32-0.29-0.33
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.27-0.32-0.29-0.33